Beta Amyloid [25-35] Peptide,Cas:131602-53-4
Beta Amyloid [25-35] Peptide
Product description
Beta-amyloid production results from cleavage in the extracellular domain of APP by the beta-secretase (BACE1), which results in the production of the APP C-terminal fragment C99. This fragment is further cleaved by the gamma-secretase at residues 40-42 to produce beta-amyloid 40 and 42 peptides. Beta-amyloid aggregation and neuritic plaque formation are pathologic hallmarks of Alzheimer disease. This peptide corresponds to the human beta-amyloid 25-35 peptide, which induces apoptosis in cells.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >90% |
Solubility | N/A |
Cas | 131602-53-4 |
Sequence | Human: H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH or H-GSNKGAIIGLM-OH |
Molecular Formula | C45H81N13O14S1 |
Storage | -20℃,protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product